The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates
2017 · Molecular Metabolism · 131 citations
https://doi.org/10.1016/j.molmet.2017.12.007
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
1.1K
Citations
14
h-index
16
i10-index
Claude Rescan is an academic researcher from Novo Nordisk (Denmark). The author has contributed to research in topics: Pancreatic function and diabetes & Liver physiology and pathology & Diabetes Management and Research. The author has an h-index of 14, co-authored 19 publications.
ORCID: 0009-0003-4111-1698https://doi.org/10.1016/j.molmet.2017.12.007
https://doi.org/10.1186/s12867-015-0042-8
Click to start Chat